Clinical Trial Update: Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of ispinesib in metastatic or unresectable renal cell carcinoma has completed, reporting results in patients with recurrent or stage III/IV diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Ispinesib (ispinesib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer | Phase 2 | Status: COMPLETED